JPH07506352A - フラビウイルス感染の治療におけるヘテロポリタングステン酸塩 - Google Patents
フラビウイルス感染の治療におけるヘテロポリタングステン酸塩Info
- Publication number
- JPH07506352A JPH07506352A JP5518767A JP51876793A JPH07506352A JP H07506352 A JPH07506352 A JP H07506352A JP 5518767 A JP5518767 A JP 5518767A JP 51876793 A JP51876793 A JP 51876793A JP H07506352 A JPH07506352 A JP H07506352A
- Authority
- JP
- Japan
- Prior art keywords
- znii
- tiiv
- coii
- ceremony
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPL221392 | 1992-05-01 | ||
PCT/AU1993/000192 WO1993021934A1 (en) | 1992-05-01 | 1993-04-30 | Heteropolytungstates in the treatment of flavivirus infections |
AU2213 | 2000-12-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH07506352A true JPH07506352A (ja) | 1995-07-13 |
Family
ID=3776137
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP5518767A Pending JPH07506352A (ja) | 1992-05-01 | 1993-04-30 | フラビウイルス感染の治療におけるヘテロポリタングステン酸塩 |
Country Status (6)
Country | Link |
---|---|
JP (1) | JPH07506352A (es) |
CN (1) | CN1082892A (es) |
CA (1) | CA2134877A1 (es) |
HU (1) | HUT71677A (es) |
MX (1) | MX9302578A (es) |
WO (1) | WO1993021934A1 (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5824706A (en) * | 1994-09-26 | 1998-10-20 | Schinazi; Raymond F. | Method, compositions, and apparatus for treating and preventing respiratory viral infections |
AUPO820197A0 (en) * | 1997-07-24 | 1997-08-14 | Biomolecular Research Institute Limited | Inorganic angiogenesis inhibitors |
AUPO995297A0 (en) * | 1997-10-24 | 1997-11-13 | Starpharma Limited | Inorganic antiviral compounds |
EP1128832A4 (en) * | 1998-08-21 | 2003-03-05 | Viropharma Inc | COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTIONS AND RELATED DISEASES |
DE102006023394A1 (de) * | 2006-05-17 | 2007-11-22 | Gerd Prof. Wengler | Herstellung und Verwendung eines antiviralen Chemotherapeutikums welches eine Wirtszelle dahingehend beeinflusst, dass die Replikation von Viren in der Zelle blockiert wird |
CN107226462A (zh) * | 2016-03-24 | 2017-10-03 | 李泽琳 | 多酸化合物、其制备方法和医药用途 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2117803B1 (es) * | 1970-12-18 | 1974-03-22 | Anvar | |
WO1990006756A1 (en) * | 1988-12-16 | 1990-06-28 | Terumo Kabushiki Kaisha | Antiviral agent |
GB8906189D0 (en) * | 1989-03-17 | 1989-05-04 | Johnson Matthey Plc | Improvements in chemical compounds |
GB9003430D0 (en) * | 1990-02-15 | 1990-04-11 | Johnson Matthey Plc | Improvements in chemical compounds |
GB9025847D0 (en) * | 1990-11-28 | 1991-01-09 | Johnson Matthey Plc | Improvements in chemical compounds |
-
1993
- 1993-04-30 HU HU9403128A patent/HUT71677A/hu unknown
- 1993-04-30 WO PCT/AU1993/000192 patent/WO1993021934A1/en active Application Filing
- 1993-04-30 JP JP5518767A patent/JPH07506352A/ja active Pending
- 1993-04-30 CA CA002134877A patent/CA2134877A1/en not_active Abandoned
- 1993-04-30 MX MX9302578A patent/MX9302578A/es unknown
- 1993-05-01 CN CN93106560A patent/CN1082892A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
CN1082892A (zh) | 1994-03-02 |
WO1993021934A1 (en) | 1993-11-11 |
HU9403128D0 (en) | 1995-02-28 |
CA2134877A1 (en) | 1993-11-11 |
MX9302578A (es) | 1994-08-31 |
HUT71677A (en) | 1996-01-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6892494B2 (ja) | パラセタモール及びイブプロフェンを含む水性配合物 | |
CA2776925C (en) | Liposome having inner water phase containing sulfobutyl ether cyclodextrin salt | |
MIYAZAKI et al. | Antitumor effect of pluronic F-127 gel containing mitomycin C on sarcoma-180 ascites tumor in mice | |
Prakash et al. | Preparation and characterization of lamivudine microcapsules using various cellulose polymers | |
EP3150212B1 (en) | Pharmaceutical solution having anti-tumor effect-enhancing and toxicity-reducing effect, and pharmaceutical composition comprising same | |
WO2017096530A1 (zh) | 癸氧喹酯固体分散体、其制备方法和用途 | |
WO2007033578A1 (fr) | Metallo-fullerenols et leur application dans la preparation de medicaments visant a inhiber la croissance tumorale | |
WO1995011033A1 (en) | Polyoxometallates in the treatment of flavivirus infections | |
CN105903021A (zh) | 一种预防和/或治疗再生障碍性贫血的富勒烯纳米材料及其应用 | |
KR20160008523A (ko) | 종양 독성과 mri를 위한 표적화 콜롤 | |
WO2004030649A3 (de) | Methode zur herstellung und stabilisierung von mikro- und nanosuspensionen mit amphiphilen und polyelektrolyten | |
JPH07506352A (ja) | フラビウイルス感染の治療におけるヘテロポリタングステン酸塩 | |
Stoll et al. | In vitro dissolution and in vivo absorption of nitrofurantoin from deoxycholic acid coprecipitates | |
JPS6328045B2 (es) | ||
CN116850192A (zh) | 一种核苷类衍生化合物的药物组合物及其制备方法和用途 | |
US20240277756A1 (en) | Silicon particles for hydrogen release | |
EP4140480A1 (en) | Drug combination and use thereof | |
TW584563B (en) | Parenteral formulation | |
Choi et al. | The Next Generation COVID‐19 Antiviral; Niclosamide‐Based Inorganic Nanohybrid System Kills SARS‐CoV‐2 | |
CN108392483B (zh) | 一种紫杉醇联合2-甲氧基雌二醇的白蛋白纳米粒的制备方法及应用 | |
WO1994012192A1 (en) | Antiviral agents | |
JP2007326796A (ja) | 金コロイドを含有する美白剤およびチロシナーゼ阻害剤 | |
Miao et al. | Preparation of DOX/BSANP and its antitumor effect on bel-7404 liver cancer cells in vitro and in vivo | |
AU4255593A (en) | Heteropolytungstates in the treatment of flavivirus infections | |
CN116327699A (zh) | 一种增强橙皮素治疗急性肝损伤效果的纳米胶束的制备及应用 |